Compare LQDA & YOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDA | YOU |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2018 | 2021 |
| Metric | LQDA | YOU |
|---|---|---|
| Price | $34.21 | $35.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | $37.40 | ★ $38.43 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | N/A | ★ 88.46 |
| EPS | N/A | ★ 1.62 |
| Revenue | $69,216,000.00 | ★ $866,298,000.00 |
| Revenue This Year | $994.17 | $17.42 |
| Revenue Next Year | $169.25 | $12.53 |
| P/E Ratio | ★ N/A | $21.81 |
| Revenue Growth | ★ 343.41 | 17.83 |
| 52 Week Low | $11.26 | $21.67 |
| 52 Week High | $36.41 | $42.29 |
| Indicator | LQDA | YOU |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 46.94 |
| Support Level | $33.45 | $35.09 |
| Resistance Level | $36.60 | $37.42 |
| Average True Range (ATR) | 1.41 | 1.42 |
| MACD | -0.25 | -0.34 |
| Stochastic Oscillator | 47.88 | 10.47 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.